| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |